Martin H. Huber Jr. - Jun 15, 2022 Form 4/A - Amendment Insider Report for Xilio Therapeutics, Inc. (XLO)

Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/23/2022, 07:30 PM
Date Of Original Report
Jun 17, 2022
Previous filing
Jun 10, 2022
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +20K $0.00 20K Jun 15, 2022 Common Stock 20K $2.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on June 15, 2022 and shall vest on July 1, 2022 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until June 1, 2026.

Remarks:

This amendment is being filed solely to correct the vesting schedule reported in the original Form 4 filed on June 17, 2022. All other information reported in the original Form 4 remains the same.